Publikasi Scopus 2024 per tanggal 30 November 2024 (994 artikel)

Smith D.J.; Queiroz-Telles F.; Rabenja F.R.; Hay R.; Bonifaz A.; Grijsen M.L.; Blaizot R.; Messina F.; Song Y.; Lockhart S.R.; Jordan A.; Cavanaugh A.M.; Litvintseva A.P.; Chiller T.; Schito M.; de Hoog S.; Vicente V.A.; Cornet M.; Dagne D.A.; Ramarozatovo L.S.; Pedrozo C.M.; Azevedo S.; Santos D.W.C.L.
Smith, Dallas J. (57577593700); Queiroz-Telles, Flávio (6701765109); Rabenja, Fahafahantsoa Rapelanoro (8871481300); Hay, Roderick (56785229200); Bonifaz, Alexandro (55989715500); Grijsen, Marlous L. (25225113700); Blaizot, Romain (57190621552); Messina, Fernando (48661362200); Song, Yinggai (57190276728); Lockhart, Shawn R. (7004708333); Jordan, Alexander (57205376515); Cavanaugh, Alyson M. (57222266626); Litvintseva, Anastasia P. (6602318537); Chiller, Tom (26638713200); Schito, Marco (6602191
57577593700; 6701765109; 8871481300; 56785229200; 55989715500; 25225113700; 57190621552; 48661362200; 57190276728; 7004708333; 57205376515; 57222266626; 6602318537; 26638713200; 6602191989; 57216303261; 7101605608; 7006797549; 56095013100; 8871480900; 59419219800; 59419303600; 59369570500
A global chromoblastomycosis strategy and development of the global chromoblastomycosis working group
2024
PLoS Neglected Tropical Diseases
2024
e0012562
0
Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA, United States; Department of Public Health, Federal University of Paraná, Curitiba, Brazil; LARTIC Laboratory, Faculty of Medicine, University of Antananarivo, Antananarivo, Madagascar; King’s College London, London, United Kingdom; Servicio de Dermatología, Hospital General de México “Dr. Eduardo Liceaga”, Mexico City, Mexico; Oxford University Clinical Research Unit Indonesia, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, United Kingdom; Department of Dermatology, Andrée Rosemon Hospital, Cayenne, 97306, French Guiana; Tropical Biome and Immunophysiopathology (TBIP), Université de Lille, CNRS, Inserm, Institut Pasteur de Lille, U1019-UMR9017-CIIL-Centre d’Infection et d’Immunité de Lille, Centre Hospitalier de Cayenne, Université de Guyane, Cayenne, French Guiana; Unidad Micología, Hospital de Enfermedades Infecciosas Francisco Javier Muñiz, Buenos Aires, Argentina; Department of Dermatology, Peking University First Hospital, Peking University, Beijing, China; Critical Path Institute, Tucson, AZ, United States; Radboudumc/CWZ Center of Expertise in Mycology, Nijmegen, Netherlands; Basic Pathology Department, Federal University of Parana, Curitiba, Brazil; Université Grenoble Alpes, Grenoble, France; Department of Control of Neglected Tropical Diseases, WHO, Geneva, Switzerland; Hôpital Universitaire Joseph Raseta Befelatanana, Antananarivo, Madagascar; Centre Hospitalier Universitaire de Befelatanana, Antananarivo, Madagascar; Department of Medicine, Federal University of Maranhão, Maranhão, São Luís, Brazil; Post-graduation Program of Health Science, Federal University of Maranhão, Maranhão, São Luís, Brazil; Department of Infectious Diseases and Infection Control, Universidade Federal do Maranhão, Maranhão, Brazil; Instituto D´Or de Pesquisa e Ensino, IDOR, Brazil; Hospital de Enfermedades Infecciosas Francisco Javier Muñiz, Buenos Aires, Argentina
Smith D.J., Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA, United States; Queiroz-Telles F., Department of Public Health, Federal University of Paraná, Curitiba, Brazil; Rabenja F.R., LARTIC Laboratory, Faculty of Medicine, University of Antananarivo, Antananarivo, Madagascar; Hay R., King’s College London, London, United Kingdom; Bonifaz A., Servicio de Dermatología, Hospital General de México “Dr. Eduardo Liceaga”, Mexico City, Mexico; Grijsen M.L., Oxford University Clinical Research Unit Indonesia, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia, Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, United Kingdom; Blaizot R., Department of Dermatology, Andrée Rosemon Hospital, Cayenne, 97306, French Guiana, Tropical Biome and Immunophysiopathology (TBIP), Université de Lille, CNRS, Inserm, Institut Pasteur de Lille, U1019-UMR9017-CIIL-Centre d’Infection et d’Immunité de Lille, Centre Hospitalier de Cayenne, Université de Guyane, Cayenne, French Guiana; Messina F., Unidad Micología, Hospital de Enfermedades Infecciosas Francisco Javier Muñiz, Buenos Aires, Argentina, Hospital de Enfermedades Infecciosas Francisco Javier Muñiz, Buenos Aires, Argentina; Song Y., Department of Dermatology, Peking University First Hospital, Peking University, Beijing, China; Lockhart S.R., Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA, United States; Jordan A., Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA, United States; Cavanaugh A.M., Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA, United States; Litvintseva A.P., Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA, United States; Chiller T., Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA, United States; Schito M., Critical Path Institute, Tucson, AZ, United States; de Hoog S., Radboudumc/CWZ Center of Expertise in Mycology, Nijmegen, Netherlands; Vicente V.A., Basic Pathology Department, Federal University of Parana, Curitiba, Brazil; Cornet M., Université Grenoble Alpes, Grenoble, France; Dagne D.A., Department of Control of Neglected Tropical Diseases, WHO, Geneva, Switzerland; Ramarozatovo L.S., Hôpital Universitaire Joseph Raseta Befelatanana, Antananarivo, Madagascar, Centre Hospitalier Universitaire de Befelatanana, Antananarivo, Madagascar; Pedrozo C.M.; Azevedo S., Department of Medicine, Federal University of Maranhão, Maranhão, São Luís, Brazil, Post-graduation Program of Health Science, Federal University of Maranhão, Maranhão, São Luís, Brazil; Santos D.W.C.L., Department of Infectious Diseases and Infection Control, Universidade Federal do Maranhão, Maranhão, Brazil, Instituto D´Or de Pesquisa e Ensino, IDOR, Brazil
Chromoblastomycosis, an implantation mycosis, is a neglected tropical disease that causes decreased quality of life, stigma, and disability. The global burden of disease is unknown and data on disease epidemiology and outcomes are severely limited by a lack of access to needed diagnostic tools and therapeutics. The World Health Organization outlined targets for chromoblastomycosis in the Road Map for Neglected Tropical Diseases 2021–2030, but little progress has been made in initiating and implementing an effective control program globally. This lack of guiding policy and progress led to the recent formation of a Global Chromoblastomycosis Working Group which has developed a global chromoblastomycosis strategy. We describe this strategy, which outlines specific steps needed to improve technical progress, strategy and service delivery, and enablers. Clinicians, researchers, public and government officials, patients, and policy makers can align their time, expertise, and resources to improve the lives of communities affected by chromoblastomycosis through this strategy. © 2024, Public Library of Science. All rights reserved.
Chromoblastomycosis; Global Health; Humans; Neglected Diseases; World Health Organization; flucytosine; imiquimod; melanin; posaconazole; proteinase; terbinafine; voriconazole; ankylosis; antifungal therapy; Article; artificial intelligence; awareness; bacterial infection; chromomycosis; cryotherapy; disease surveillance; ectropion; erythema; health care personnel; health infrastructure; human; immune response; lymphedema; malignant transformation; metagenomics; microscopy; morbidity; mortality; mycetoma; mycosis; phagocytosis; pilot study; quality of life; risk factor; sporotrichosis; squamous cell carcinoma; tropical disease; diagnosis; drug therapy; epidemiology; global health; microbiology; neglected disease; prevention and control; World Health Organization
Public Library of Science
19352727
39405322
Article
Q1
1258
3050